EPC

Edgewell Personal Care Co Consumer Staples Perfumes, Cosmetics & Other Toilet Preparations Russell 3000
$28.57Close $1.3BMarket cap $15.60 – $29.5052-week range Nov 12, 2026Next report · before the open

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 84 · stronger than 84% of stocks over 12 months
  • Near its high 3% below its 52-week high

Cautions

  • Earnings shrinking EPS −53% year on year
  • Results soon Nov 12, 2026, in 11 days
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Sep 30, 2025 · filed Aug 5, 2026
Off 12-month high 3%
1wk up 1.8% price change
1mo up 5.9% price change
12-month return up 52% market up 11% · its own up 44%
F-score 5 / 9 Mixed
Altman Z 1.58 Elevated risk
P/E 52.3× price / earnings
PEG — P/E / EPS growth
P/B 0.9× price / book
Earnings yield up 3.9% EBIT / enterprise value
Cheaper than 66% of the market · cheap
Revenue growth down 1% year on year
EPS growth down 53% latest quarter · +85 pts
Sales growth up 2% latest quarter · +1 pts
ROE up 2% return on equity
Free cash margin up 2% $41.4M FCF
D/E 0.89 long-term debt / equity
Net debt / EBITDA 6.2×
Interest cover 1.3×EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • took on more long-term debt
  • gross margin narrowed
  • assets working less efficiently
  • profitable on its assets
  • generating cash from operations
  • profits backed by cash
  • short-term liquidity improved
  • no new shares issued

Repair signals

  • FCF turned positive ($-288M → $41M)

Trade setup

ATR% 3.4% $0.97 a day · 2×ATR $26.64
RS 84 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.8× vs 50-day average
Up/down volume 0.93 50 sessions
Implied move — no option chain · report Nov 12, 2026
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

4 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
  • Interest is covered, but thinly Earnings before interest cover the interest bill 1.3 times, leaving little room if profits fall.
  • Heavily indebted Net debt is 6.2 times EBITDA — roughly 6 years of earnings before interest, tax and depreciation to repay borrowings in full.
  • Revenue shrinking Revenue fell 1.3% over the year, from $2.3B to $2.2B.
Last reported Aug 5, 2026
Results reaction Aug 5, 2026-1% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.2B -1% on FY2024
$0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.9B FY2021 · $2.1B FY2022 · $2.2B FY2023 · $2.3B FY2024 · $2.3B FY2025 · $2.2B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $25.4M -74% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $67.6M FY2021 · $117.8M FY2022 · $99.5M FY2023 · $114.7M FY2024 · $98.6M FY2025 · $25.4M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $41.4M back to a profit
-$500M $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $184.9M FY2021 · $172.2M FY2022 · $45.6M FY2023 · -$265.6M FY2024 · -$287.5M FY2025 · $41.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 42%
  • Net 1%
  • Free cash 2%
-20% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 45% · Net 3% · Free cash 9% FY2021 · Gross 46% · Net 6% · Free cash 8% FY2022 · Gross 41% · Net 5% · Free cash 2% FY2023 · Gross 42% · Net 5% · Free cash -12% FY2024 · Gross 42% · Net 4% · Free cash -13% FY2025 · Gross 42% · Net 1% · Free cash 2%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.2B net debt
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $364.7M · Long-term debt $1.2B FY2021 · Cash $479.2M · Long-term debt $1.2B FY2022 · Cash $188.7M · Long-term debt $1.4B FY2023 · Cash $216.4M · Long-term debt $1.4B FY2024 · Cash $209.1M · Long-term debt $1.3B FY2025 · Cash $225.7M · Long-term debt $1.4B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 46.46m -14.5% since FY2020
54.37m 46.46m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 54.36m FY2021 · 54.37m FY2022 · 51.57m FY2023 · 50.12m FY2024 · 48.92m FY2025 · 46.46m
  FY2020Sep 30, 2020 FY2021Sep 30, 2021 FY2022Sep 30, 2022 FY2023Sep 30, 2023 FY2024Sep 30, 2024 FY2025Sep 30, 2025
Revenue $1.9B $2.1B $2.2B $2.3B $2.3B $2.2B
Gross margin 45% 46% 41% 42% 42% 42%
Operating income $176.0M $239.9M $182.3M $227.0M $199.3M $96.6M
Net income $67.6M $117.8M $99.5M $114.7M $98.6M $25.4M
Net margin 3% 6% 5% 5% 4% 1%
Earnings per share $1.24 $2.13 $1.86 $2.21 $1.97 $0.53
Free cash flow $184.9M $172.2M $45.6M -$265.6M -$287.5M $41.4M
Free cash margin 9% 8% 2% -12% -13% 2%
Cash $364.7M $479.2M $188.7M $216.4M $209.1M $225.7M
Long-term debt $1.2B $1.2B $1.4B $1.4B $1.3B $1.4B
Shareholders' equity $1.4B $1.6B $1.5B $1.5B $1.6B $1.6B
Shares outstanding 54.36m 54.37m 51.57m 50.12m 48.92m 46.46m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jun 30, 2026 36d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Feb 9, 2026 Quarterly ↗ Dec 31, 2025 40d
Nov 18, 2025 Annual ↗ Sep 30, 2025 49d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Feb 10, 2025 Quarterly ↗ Dec 31, 2024 41d
Nov 14, 2024 Annual ↗ Sep 30, 2024 45d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 8, 2024 Quarterly ↗ Mar 31, 2024 38d
Feb 7, 2024 Quarterly ↗ Dec 31, 2023 38d
Nov 28, 2023 Annual ↗ Sep 30, 2023 59d

Current reports